HIV-1 diversity: A tool for studying the pandemic;A diversidade do HIV-1: Uma ferramenta para o estudo da pandemia

Cadernos de Saude Publica

Volumn 22, Issue 3, 2006, Pages 473-484

  Pinto, Mônica Edelenyi ^a   Struchiner, Claudio José ^b,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acquired Immunodeficiency Syndrome; HIV 1; Molecular Epidemiology

Indexed keywords

EID: 33646407064     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/s0102-311x2006000300002     Document Type: Review

References (85)

1. McDade JE, Anderson BE. Molecular epidemiology: applications of nucleic acid amplification and sequence analysis. Epidemiol Rev 1996; 18:90-7.
2. Loussert-Ajaka I, Chaix ML, Korber B, Letourneur F, Gomas E, Allen E, et al. Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995; 69:5640-9.
3. Rambaut A, Posada D, Crandall KA, Holmes EC. The causes and consequences of HIV evolution. Nat Rev Genet 2004; 5:52-61.
4. Gürtler L, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994; 68:1581-5.
5. Simon F, Mauclère P, Roques P, Loussert-Ajaka I, Müller-Trutwin MC, Saragosti S, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998; 4:1032-7.
6. Osmanov S, Pattou C, Walter N, Schwartänder B, Esparza J; WHO-UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr 2002; 29:184-90.
7. Overbaugh J, Bangham CRM. Selection forces and constrains on retroviral sequence variation. Science 2001; 292:1106-9.
8. Markowitz M, Louie M, Hurley A, Sun E, Mascio MD, Perelson AS, et al. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 2003; 77:5037-8.
9. Hu WS, Temin HM. Retroviral recombination and reverse transcription. Science 1990; 250:1227-33.
10. Janini LM, Tanuri A, Schechter M, Peralta JM, Vicente ACP, Torre ND, et al. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998; 177:227-31.
11. Quiñones-Mateu ME, Arts EJ. Fitness: implications for drug resistence, disease progression, and global epidemic evolution. In: Kuiken CL, Foley B, Hahn B, Korber B, Marx PA, McCutchan F, et al. editors. HIV sequence compendium. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 2001. p. 134-70.
12. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, et al. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol 1992; 66:3183-7.
13. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287:607-14.
14. sm) closely related to HIV-2. Nature 1989; 339:389-92.
15. Fukasawa M, Miura T, Hasegawa A, Morikawa S, Tsujimoto H, Miki K, et al. Sequence of simian immunodeficiency virus from african green monkey, a new member of the HIV/SIV group. Nature 1988; 333:457-61.
16. Doolittle RF, Feng DF, Mcclure MA, Johnson MS. Retrovirus phylogeny and evolution. Curr Top Microbiol Immunol 1990; 157:1-18.
17. Vidal N, Peeters M, Mulanga-Kabeya C, Nzilambi N, Robertson D, Ilunga W, et al. Unprecedented degree of human immunodeficiency virus yype 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000; 74:10498-507.
18. Zhu T, Korber B, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998; 391:594-7.
19. Huet T, Cheynier R, Meyerhans A, Roelants G, Wain-Hobson S. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature 1990; 345:356-9.
20. Hayami M, Ido E, Miura T. Survey of simian immunodeficiency virus among nonhuman primate populations. Curr Top Microbiol Immunol 1994; 188:1-19.
21. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS. AIDS 1997; 11:17-36.
22. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rübsamen-Waigmann H, et al. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science 1993; 262:1257-61.
23. Bachmann MH, Delwart EL, Shpaer EG, Lingenfelter P, Singal R, Mullins JI, et al. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. AIDS Res Hum Retroviruses 1994; 10:1345-53.
24. Heyndrickx L, Janssens W, Zekeng L, Musonda R, Anagonou S, van der Awera G, et al. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. J Virol 2000; 74:363-70.
25. Pieniazek D, Janini LM, Ramos A, Tanuri A, Schechter M, Peralta JM, et al. HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerg Infect Dis 1995; 1:86-8.
26. Pinto ME, Tanuri A, Schechter M. Molecular and epidemiologic evidence for the discontinuous introduction of subtypes B and F into Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:310-2.
27. Holguín A, Rodés B, Dietrich U, Soriano V. Human Immunodeficiency Virus Type 1 subtypes circulating in Spain. J Med Virol 1999; 59:189-93.
28. Morgado MG, Guimarães ML, Neves JRI, Santos VGV, Carvalho MIL, Castello-Branco LR, et al. Molecular epidemiology of HIV in Brazil: polymorphism of the antigenically distinct HIV-1 B subtype strains. Mem Inst Oswaldo Cruz 1998; 93:383-6.
29. Covas DT, Bíscaro TA, Kashima S, Duarte G, Machado AA. High frequency of the GWG (Pro Trp) envelope variant of HIV-1 in Southeast Brazil. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:74-9.
30. Guimarães ML, dos Santos Moreira A, Loureiro R, Galvão-Castro B, Morgado MG; Brazilian Network for HIV Isolation and Characterization. High frequency of recombinant genomes in HIV type 1 samples from Brazilian southeastern and southern regions. AIDS Res Hum Retroviruses 2002; 18:1261-9.
31. Peeters M. Recombinant HIV sequences: their role in the global epidemics. In: Kuiken CL, Foley B, Hahn B, Korber B, Marx PA, McCutchan F, et al. editors. HIV sequence compendium. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 2000. p. 2-23.
32. Lukashov VV, Huismans R, Rakhmanova AG, Lisitsina ZN, Akhtyrskaya NA, Vlasov NN, et al. Circulation of subtype A and gagA/envB recombinant HIV type 1 strains among injecting drug users in St. Petersburg, Russia, correlates with geographical origin of infections. AIDS Res Hum Retroviruses 1999; 15:1577-83.
33. Fonjungo PN, Mpoudi EN, Torimiro JN, Alemnji GA, Eno LT, Nkengasong JN, et al. Presence of diverse human immunodeficiency virus type 1 viral variants in Cameroon. AIDS Res Hum Retroviruses 2000; 16:1319-24.
34. Thomson MM, Delgado E, Manjon N, Ocampo A, Villahermosa ML, Marino A, et al. HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS 2001; 15:509-16.
35. Yirrell DY, Kaleebu P, Morgan D, Watera C, Magambo B, Lyagoba F, et al. Inter and intra-genetic intersubtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 2002; 16:279-86.
36. Soto-Ramirez LE, Renjifo B, Mclane MF, Marlink R, O'Hara C, Sutthent R, et al. HIV-1 Langerhans' cell tropism associated with heterosesual transmission of HIV. Science 1996; 271:1291-3.
37. GER, a new, highly replicative and highly cytopathic HIV type 1 strain of D genotype. AIDS Res Hum Retroviruses 1994; 10:1043-5.
38. Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279:35-40.
39. Alaeus A. Significance of HIV-1 genetic subtypes. Scand J Infect Dis 2000; 32:455-63.
40. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001; 344:720-5.
41. Essex E. Human immunodeficiency viruses in the developing world. Adv Virus Res 1999; 53:71-88.
42. van Harmelen J, Wood R, Lambrick M, Rybicki EB, Williamson AL, Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997; 11:81-7.
43. Dittmar MT, Simmons G, Hibbitts S, O'Hare M, Louisirirotchanakul S, Beddows S, et al. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J Virol 1997; 71:8008-13.
44. Pope M, Ho DD, Moore JP, Weber J, Dittmar MT. Different subtypes of HIV-1 and cutaneous dendritic cells. Science 1997; 278:786-8.
45. Karita E, Nkengasong JN, Willems B, Vanham G, Fransen K, Heyndrickx L, et al. Macrophage-tropism of HIV-1 isolates of different genetic subtypes. AIDS 1997; 11:1303-4.
46. Korber BTM, MacInnes K, Smith RF, Myers G. Mutational trends in the V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994; 68:6730-44.
47. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh CC, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179:68-73.
48. Kaleebu P, Ross A, Morgan D, Yirrell D, Oram J, Rutemberwa A, et al. Relationship between HIV-1 env subtypes A and D and disease progression in a rural ugandan cohort. AIDS 2001; 15:293-9.
49. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, et al. Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 2002; 185:1244-50.
50. Santoro-Lopes G, Harrison LH, Tavares MD, Xexéo A, Dos Santos ACE, Schechter M. HIV disease progression and V3 serotypes in Brazil: is B different from B-Br? AIDS Res Hum Retroviruses 2000; 16:953-8.
51. Casseb J, Komninakis S, Abdalla L, Brigido LF, Rodrigues R, Araujo F, et al. HIV disease progression: is the Brazilian variant subtype B' (GWGR motif) less pathogenic than US/European subtype B (GPGR)? Int J Infect Dis 2002; 6:164-9.
52. Treurnicht FK, Smith TL, Engelbrecht S, Claassen M, Robson BA, Zeier M, et al. Genotypic and phenotypic analysis of the env gene from South African HIV-1 subtype B and C isolates. J Med Virol 2002; 68:141-6.
53. Fouchier RAM, Schuitemaker H. Molecular determinants of human immunodeficiency virus type 1 phenotype variability. Eur J Clin Invest 1996; 26:175-85.
54. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, Quiñones-Mateu ME, et al. Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 2003; 77:1021-38.
55. Neilson JR, John GC, Carr JK, Lewis P, Kreiss JK, Jackson S, et al. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J Virol 1999; 73:4393-403.
56. Mason CJ, Kitsiripornchai S, Markowitz LE, Chanbancherd P, Supapongse T, Jugsudee A, et al. Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:165-73.
57. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, et al. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999; 131:502-6.
58. Irwin KL, Pau CP, Lupo D, Pienazek D, Luo CC, Olivo N, et al. Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel site for monitoring HIV genetic diversity in North America. J Infect Dis 1997; 176:1629-33.
59. Sullivan PS, Do AN, Ellenberger D, Pau CP, Paul S, Robbins K, et al. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States. J Infect Dis 2000; 181:463-9.
60. Weidle PJ, Ganea CE, Irwin KL, Pienazek D, Mcgowan JP, Olivo N, et al. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: a sentinel site for monitoring HIV genetic diversity in the United States. J Infect Dis 2000; 181:470-5.
61. Bobkov A, Kazennova E, Selimova L, Bobkova M, Khanina T, Ladnaya N, et al. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: identification of subtype A, subtype B, and novel gagA/envB recombinants. AIDS Res Hum Retroviruses 1998; 14:669-76.
62. Hussein M, Abebe A, Pollakis G, Brouwer M, Petros B, Fontanet AL, et al. HIV-1 subtype C in commerical sex workers in Addis Ababa, Ethiopia. J Acquir Immune Defic Syndr 2000; 23:120-7.
63. Lasky M, Perret JL, Peeters M, Bibollet-Ruche F, Liegeois F, Patrel D, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997; 11:43-51.
64. Limpakarnjanarat K, Ungchusak K, Mastro TD, Young NL, Likhityingvara C, Sangwonloy O, et al. The epidemiological evolution of HIV-1 subtypes B and E among heterosexuals and injecting drug users in Thailand, 1992-1997. AIDS 1998; 12:1108-9.
65. Irwin KL, Olivo N, Schable C, Weber JT, Janssen R, Ernst J. Absence of human immunodeficiency virus type 2 infection among patients in a hospital serving a New York community at high risk for infection. Transfusion 1996; 36:731-3.
66. Barin F, Courouce AM, Pillonel J, Buzelay L. Increasing diversity of HIV-1 M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 1997; 11:1503-8.
67. Alaeus A, Leiner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997; 11:199-202.
68. Op de Coul ELM, Coutinho RA, van der Schoot A, van Doornum GJJ, Lukashov VV, Goudsmit J, et al. The impact of immigration on the env HIV-1 subtype distribution among heterosexuals in the Netherlands: influx of subtype B and non-B strains. AIDS 2001; 15:2277-86.
69. McCutchan FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, et al. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992; 8:1887-95.
70. Nopkesorn T, Mastro TD, Sangkharomya S, Sweat M, Singharaj P, Limpakarnjanarat K, et al. HIV-1 infection in young men in northern Thailand. AIDS 1993; 7:1233-9.
71. Kalish ML, Baldwin A, Raktham S, Wasi C, Luo CC, Schochetman G, et al. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS 1995; 9:851-7.
72. Gao F, Robertson DL, Morrison SG, Hui H, Craig S, Decker J, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70:7013-29.
73. Subbarao S, Limpakarnjanarat K, Mastro TD, Bhumisawasdi J, Warachit P, Jayavasu C, et al. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998; 14:319-27.
74. Kitayaporn D, Vanichseni S, Mastro TD, Raktham S, Vaniyapongs T, Des Jarlais DC, et al. Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:289-95.
75. Subbarao S, Vanichseni S, Hu DJ, Kitayaporn D, Choopanya K, Raktham S, et al. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses 2000; 16:699-707.
76. Bobkov A, Cheingsong-Popov R, Selimova L, Ladnaya N, Kazennova E, Kravchenko A, et al. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain. AIDS Res Hum Retroviruses 1997; 13:1195-201.
77. Lukashov VV, Karamov EV, Eremin VF, Titov LP, Goudsmit J. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus. AIDS Res Hum Retroviruses 1998; 14:1299-303.
78. Liitsola K, Holm K, Bobkov A, Pokrovsky V, Smolskaja T, Leinikki P, et al. An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: low requirements for sequence identity in recombination. AIDS Res Hum Retroviruses 2000; 16:1047-53.
79. Kuiken C, Thakallapalli R, Eskild A, De Ronde A. Genetic analysis reveals epidemiologic patterns in the spread of human immunodeficiency virus. Am J Epidemiol 2000; 152:814-22.
80. Lemey P, Salemi M, Wang B, Duffy M, Hall WH, Saksena NK, et al. Site stripping based on likelihood ratio reduction is a useful tool to evaluate the impact of non-clock-like behavior on viral phylogenetic reconstructions. FEMS Immunol Med Microbiol 2003; 39:125-32.
81. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000; 288:1789-96.
82. Abebe A, Lukashov VV, Pollakis G, Kliphuis A, Fontanet AL, Goudsmit J, et al. Timing of the HIV-1 subtype C epidemic in Ethiopia based on early virus strains and subsequent virus diversification. AIDS 2001; 15:1555-61.
83. Robbins KE, Lemey P, Pybus OG, Jaffe HW, Youngpairoj AS, Brown TM, et al. U.S. human immunodeficiency virus type 1 epidemic: date of origin, population history, and characterization of early strains. J Virol 2003; 77:6359-66.
84. Lukashov VV, Goudsmit J. Recent evolutionary history of human immunodeficiency virus type 1 subtype B: reconstruction of epidemic onset based on sequence distances to the common ancestor. J Mol Evol 2002; 54:680-91.
85. Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004; 303:327-32.